DermTech Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
DermTech (DMTK) Misses Q1 EPS by 13c
May 13, 2021 4:49 PM EDTDermTech (NASDAQ: DMTK) reported Q1 EPS of ($0.55), $0.13 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $2.11 million.
Second Quarter 2021 Guidance:
Management estimates that second quarter 2021 assay revenue will be between $2.4... More
